Incidence and risk of osteonecrosis of the jaw among the Taiwan osteoporosis population

被引：0
|
作者：
T.-C. Lin
C.-Y. Yang
Y.-H. Kao Yang
S.-J. Lin
机构：
[1] National Cheng Kung University,Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine
[2] National Cheng Kung University,Department of Orthopedics, College of Medicine
[3] National Cheng Kung University Hospital,Department of Orthopedics
[4] National Cheng Kung University,Health Outcome Research Center
[5] University of Illinois at Chicago,Department of Pharmacy Administration
来源：
Osteoporosis International | 2014年 / 25卷
关键词：
Alendronate; Osteonecrosis of the jaw; Osteoporosis; Pharmacoepidemiology;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1503 / 1511
页数：8
相关论文
共 50 条
  • [1] Incidence and risk of osteonecrosis of the jaw among the Taiwan osteoporosis population
    Lin, T. -C.
    Yang, C. -Y.
    Yang, Y. -H. Kao
    Lin, S. -J.
    OSTEOPOROSIS INTERNATIONAL, 2014, 25 (05) : 1503 - 1511
  • [2] Incidence of osteonecrosis of the jaw among users of bisphosphonates with selected cancers or osteoporosis
    Tennis, Patricia
    Rothman, Kenneth J.
    Bohn, Rhonda L.
    Tan, Hiangkiat
    Zavras, Athanasios
    Laskarides, Constantinos
    Calingaert, Brian
    Anthony, Mary S.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 (08) : 810 - 817
  • [3] Incidence of Osteonecrosis of the Jaw Among Users of Bisphosphonates with Selected Cancers or Osteoporosis
    Mikosch, P.
    JOURNAL FUR MINERALSTOFFWECHSEL, 2012, 19 (03): : 137 - 137
  • [4] Alendronate Use and the Risk of Osteonecrosis of Jaw in Taiwan
    Huang, Weng-Foung
    Lu, Pei-Yu
    Hsieh, Chi-Feng
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 412 - 412
  • [5] ALENDRONATE USE AND THE RISK OF OSTEONECROSIS OF JAW IN TAIWAN
    Huang, W. F.
    Lu, P. Y.
    Hsieh, C. F.
    VALUE IN HEALTH, 2012, 15 (07) : A671 - A671
  • [6] Incidence Rate of Potential Osteonecrosis of the Jaw Among Women with Postmenopausal Osteoporosis Treated with Prolia or Bisphosphonates
    Xue, Fei
    Wagman, Rachel B.
    Yue, Susan
    Smith, Shawna
    Arora, Tarun
    Curtis, Jeffrey R.
    Ehrenstein, Vera
    Sorensen, Henrik T.
    Tell, Grethe
    Kieler, Helle
    Wang, Florence T.
    Dore, David D.
    Sprafka, J. Michael
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [7] ZOLEDRONATE-RELATED OSTEONECROSIS OF THE JAW IN OSTEOPOROSIS: INCIDENCE, RISK FACTORS AND COMPARISON TO ORAL BISPHOSPHONATES
    Amigues, C.
    Fresse, A.
    Roux, C.
    Gauthier, S.
    Vieillard, M. H.
    Drici, M. D.
    Breuil, V.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 158 - 158
  • [8] Zoledronate and osteonecrosis of the jaw in osteoporosis: incidence and risk factors. Analysis of the French Pharmacovigilance Database
    Amigues, Claire
    Fresse, Audrey
    Roux, Christian Hubert
    Gauthier, Sophie
    Vieillard, Marie-Helene
    Drici, Milou-Daniel
    Breuil, Veronique
    JOINT BONE SPINE, 2023, 90 (06)
  • [9] Osteonecrosis of the jaw osteoporosis therapy
    Kessenich, Cathy R.
    NURSE PRACTITIONER, 2010, 35 (07): : 51 - 53
  • [10] Incidence of osteonecrosis of the jaw in Japanese osteoporosis patients taking minodronic acid
    Taguchi, Akira
    Uemura, Yukari
    Imai, Takumi
    Tanaka, Shiro
    Ohta, Hiroaki
    Nakamura, Toshitaka
    Orimo, Hajime
    Sugimoto, Toshitsugu
    Soen, Satoshi
    Shiraki, Masataka
    JOURNAL OF BONE AND MINERAL METABOLISM, 2019, 37 (05) : 886 - 892
12345